2,159
Views
24
CrossRef citations to date
0
Altmetric
Review

Nanovaccine: an emerging strategy

&
Pages 1273-1290 | Received 02 Jun 2021, Accepted 21 Sep 2021, Published online: 29 Sep 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yarong Zeng, Feihong Zou, Ningshao Xia & Shaowei Li. (2023) In-depth review of delivery carriers associated with vaccine adjuvants: current status and future perspectives. Expert Review of Vaccines 22:1, pages 681-695.
Read now
Qiliang Yin, Ying Wang, Yipeng Xiang & Feng Xu. (2022) Nanovaccines: Merits, and diverse roles in boosting antitumor immune responses. Human Vaccines & Immunotherapeutics 18:6.
Read now

Articles from other publishers (22)

Wanli Song, Pengfei Jia, Yaping Ren, Junmiao Xue, Bingqian Zhou, Xinkai Xu, Yansheng Shan, Jing Deng & Qihui Zhou. (2023) Engineering white blood cell membrane-camouflaged nanocarriers for inflammation-related therapeutics. Bioactive Materials 23, pages 80-100.
Crossref
Cheol-Gyun Kim, Jeong-Cheol Lee, Do-Bin Ju, Seo-Kyung Kim, Cheol-Heui Yun & Chong-Su Cho. (2023) Enhancement of Immune Responses Elicited by Nanovaccines through a Cross-Presentation Pathway. Tissue Engineering and Regenerative Medicine.
Crossref
Kirsten Pondman, Séverine Le Gac & Uday Kishore. (2023) Nanoparticle-induced immune response: Health risk versus treatment opportunity?. Immunobiology 228:2, pages 152317.
Crossref
Feng Xu, Ye Yuan, Ying Wang & Qiliang Yin. (2023) Emerging peptide-based nanovaccines: From design synthesis to defense against cancer and infection. Biomedicine & Pharmacotherapy 158, pages 114117.
Crossref
Hoorieh Soleimanjahi & Seyed-Mahmood Seyed-Khorrami. 2023. Cancer Nanotechnology. Cancer Nanotechnology 229 252 .
Tania B. Lopez-Mendez, Raffaele Strippoli, Flavia Trionfetti, Pilar Calvo, Marco Cordani & Juan Gonzalez-Valdivieso. 2023. Cancer Nanotechnology. Cancer Nanotechnology 325 383 .
Gandarvakottai Senthilkumar Arumugam, Kannan Damodharan, Mukesh Doble & Sathiah Thennarasu. (2022) Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity. Molecular Biomedicine 3:1.
Crossref
Wen-lu Yan, Tian-qun Lang, Wen-hui Yuan, Qi Yin & Ya-ping Li. (2022) Nanosized drug delivery systems modulate the immunosuppressive microenvironment to improve cancer immunotherapy. Acta Pharmacologica Sinica 43:12, pages 3045-3054.
Crossref
Dandan Wang, Wenxing Gu, Weiliang Chen, Jin Zhou, Le Yu, Byung Kook Kim, Xuenong Zhang & Jong Seung Kim. (2022) Advanced nanovaccines based on engineering nanomaterials for accurately enhanced cancer immunotherapy. Coordination Chemistry Reviews 472, pages 214788.
Crossref
Lei Lei, Dennis Huang, Huile Gao, Bin He, Jun Cao & Nicholas A. Peppas. (2022) Hydrogel-guided strategies to stimulate an effective immune response for vaccine-based cancer immunotherapy. Science Advances 8:47.
Crossref
Rajashri Bezbaruah, Vivek P. Chavda, Lawandashisha Nongrang, Shahnaz Alom, Kangkan Deka, Tutumoni Kalita, Farak Ali, Bedanta Bhattacharjee & Lalitkumar Vora. (2022) Nanoparticle-Based Delivery Systems for Vaccines. Vaccines 10:11, pages 1946.
Crossref
Xi Yang, Yuanfeng Wei, Lingnan Zheng, Jia You, Huawei Li, Ling Gao, Changyang Gong & Cheng Yi. (2022) Polyethyleneimine-based immunoadjuvants for designing cancer vaccines. Journal of Materials Chemistry B 10:40, pages 8166-8180.
Crossref
Nan Zhang, Mengru Li, Ziye Hou, Lan Ma, Ayesha Younas, Ziyi Wang, Xinchi Jiang & Jianqing Gao. (2022) From vaccines to nanovaccines: A promising strategy to revolutionize rheumatoid arthritis treatment. Journal of Controlled Release 350, pages 107-121.
Crossref
Xingliang Fang, Huanrong Lan, Ketao Jin, Daojun Gong & Jun Qian. (2022) Nanovaccines for Cancer Prevention and Immunotherapy: An Update Review. Cancers 14:16, pages 3842.
Crossref
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll & Guangfu Li. (2022) Cancer Immunotherapy and Delivery System: An Update. Pharmaceutics 14:8, pages 1630.
Crossref
Yuhan Tu, Zhiang Yao, Wenjing Yang, Shanhui Tao, Bin Li, Yun Wang, Zhijian Su & Shijun Li. (2022) Application of Nanoparticles in Tumour Targeted Drug Delivery and Vaccine. Frontiers in Nanotechnology 4.
Crossref
Dominic Augustine, C. Pushpalatha, S.V. Sowmya, Chhaya Kumar, Elizabeth Abbu Varghese & V.S. Gayathri. 2022. Nanovaccinology as Targeted Therapeutics. Nanovaccinology as Targeted Therapeutics 301 318 .
Chan Feng, Yongjiang Li, Bijan Emiliano Ferdows, Dylan Neal Patel, Jiang Ouyang, Zhongmin Tang, Na Kong, Enguo Chen & Wei Tao. (2022) Emerging vaccine nanotechnology: From defense against infection to sniping cancer. Acta Pharmaceutica Sinica B 12:5, pages 2206-2223.
Crossref
Shuxiong Chen, Benjamin Evert, Adetayo Adeniyi, Mercè Salla‐Martret, Linda H.‐L. Lua, Victoria Ozberk, Manisha Pandey, Michael F. Good, Andreas Suhrbier, Peter Halfmann, Yoshihiro Kawaoka & Bernd H. A. Rehm. (2021) Ambient Temperature Stable, Scalable COVID‐19 Polymer Particle Vaccines Induce Protective Immunity. Advanced Healthcare Materials 11:3, pages 2102089.
Crossref
Nefeli Lagopati, Efstathios P. Efstathopoulos, Dimitris Veroutis, Hector Katifelis, George Theocharous, Pavlos Pantelis, Konstantinos Evangelou, Vassilis G. Gorgoulis & Maria Gazouli. 2022. Pharmaceutical Nanobiotechnology for Targeted Therapy. Pharmaceutical Nanobiotechnology for Targeted Therapy 489 519 .
Lu Shi & Hongchen Gu. (2021) Emerging Nanoparticle Strategies for Modulating Tumor-Associated Macrophage Polarization. Biomolecules 11:12, pages 1912.
Crossref
Dandan Wang, Wenxing Gu, Weiliang Chen, Jin Zhou, Le Yu, Byung Kook Kim, Xuenong Zhang & Jong Seung Kim. (2022) Advanced Nanovaccines Based on Engineering Nanomaterials for Accurately Enhanced Cancer Immunotherapy. SSRN Electronic Journal.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.